Published in Fungal Biol on October 04, 2011
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile. PLoS One (2013) 1.18
Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications. Antimicrob Agents Chemother (2013) 0.98
Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella. Virulence (2013) 0.96
Examining the virulence of Candida albicans transcription factor mutants using Galleria mellonella and mouse infection models. Front Microbiol (2015) 0.90
Photodynamic and antibiotic therapy impair the pathogenesis of Enterococcus faecium in a whole animal insect model. PLoS One (2013) 0.89
RNA Enrichment Method for Quantitative Transcriptional Analysis of Pathogens In Vivo Applied to the Fungus Candida albicans. MBio (2015) 0.86
Divergent and Convergent Evolution of Fungal Pathogenicity. Genome Biol Evol (2016) 0.85
Choosing an appropriate infection model to study quorum sensing inhibition in Pseudomonas infections. Int J Mol Sci (2013) 0.79
Comparison of virulence between Paracoccidioides brasiliensis and Paracoccidioides lutzii using Galleria mellonella as a host model. Virulence (2015) 0.79
The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system. Med Mycol (2012) 0.79
Galleria mellonella as a model host for microbiological and toxin research. Virulence (2016) 0.78
Development of quantitative proteomics using iTRAQ based on the immunological response of Galleria mellonella larvae challenged with Fusarium oxysporum microconidia. PLoS One (2014) 0.76
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis. Front Microbiol (2017) 0.75
Fluconazole Pharmacokinetics in the Galleria mellonella Larvae and performance evaluation of a Bioassay compared to LC-MS/MS for haemolymph specimens. Antimicrob Agents Chemother (2017) 0.75
Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogies. Proc Natl Acad Sci U S A (1998) 6.46
Comparative genomics reveals mobile pathogenicity chromosomes in Fusarium. Nature (2010) 5.79
Mycotoxins. Clin Microbiol Rev (2003) 5.59
Insect hemocytes and their role in immunity. Insect Biochem Mol Biol (2002) 3.94
Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev (1994) 3.58
Fusarium infections in immunocompromised patients. Clin Microbiol Rev (2007) 3.44
Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun (2005) 3.13
Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis (2002) 2.44
The genome of Nectria haematococca: contribution of supernumerary chromosomes to gene expansion. PLoS Genet (2009) 2.29
Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol (2008) 2.16
Human fusariosis. Clin Microbiol Infect (2004) 2.02
The Fungal Genetics Stock Center: a repository for 50 years of fungal genetics research. J Biosci (2010) 2.01
Members of the Fusarium solani species complex that cause infections in both humans and plants are common in the environment. J Clin Microbiol (2006) 1.99
Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence (2010) 1.88
Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Microbiol (2000) 1.86
Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis (2001) 1.86
Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella. Mycopathologia (2004) 1.63
Molecular biology of Fusarium mycotoxins. Int J Food Microbiol (2007) 1.61
Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol (2010) 1.51
Vertebrate endothermy restricts most fungi as potential pathogens. J Infect Dis (2009) 1.51
Lack of host specialization in Aspergillus flavus. Appl Environ Microbiol (2000) 1.49
Gibberella from A (venaceae) to Z (eae). Annu Rev Phytopathol (2003) 1.40
Accidental virulence, cryptic pathogenesis, martians, lost hosts, and the pathogenicity of environmental microbes. Eukaryot Cell (2007) 1.38
Fluctuations in haemocyte density and microbial load may be used as indicators of fungal pathogenicity in larvae of Galleria mellonella. Microbes Infect (2003) 1.34
Molecular phylogenetic, morphological, and mycotoxin data support reidentification of the Quorn mycoprotein fungus as Fusarium venenatum. Fungal Genet Biol (1998) 1.28
Morphogenesis in germinating Fusarium graminearum macroconidia. Mycologia (2006) 1.24
Experimental pathogenicity of four opportunist Fusarium species in a murine model. J Med Microbiol (1999) 1.24
Fusarium infections of the skin. Curr Opin Infect Dis (2000) 1.23
Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy. Antimicrob Agents Chemother (2008) 1.14
Conidiation color mutants of Aspergillus fumigatus are highly pathogenic to the heterologous insect host Galleria mellonella. PLoS One (2009) 1.14
A peptidomics study reveals the impressive antimicrobial peptide arsenal of the wax moth Galleria mellonella. Insect Biochem Mol Biol (2009) 1.13
The challenge of managing fusariosis. Virulence (2011) 1.10
Entomogenous Fusarium species. Mycopathologia (1983) 1.07
Enniatins fromFusarium avenaceum isolated from balsam fir foliage and their toxicity to spruce budworm larvae,Choristoneura fumiferana (Clem.) (Lepidoptera: Tortricidae). J Chem Ecol (1988) 1.00
Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine (Baltimore) (2011) 0.97
Experimental fusarial hyalohyphomycosis in a murine model. J Infect Dis (1991) 0.95
Fusarium solani species complex isolates conspecific with Fusarium solani f. sp. cucurbitae race 2 from naturally infected human and plant tissue and environmental sources are equally virulent on plants, grow at 37 degrees C and are interfertile. Environ Microbiol (2007) 0.93
The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella. Insect Biochem Mol Biol (2007) 0.88
Sewage and community shower drains are environmental reservoirs of Fusarium solani species complex group 1, a human and plant pathogen. Environ Microbiol (2007) 0.80
Management of rare fungal infections. Curr Opin Infect Dis (2004) 0.79
CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science (2005) 8.97
Google trends: a web-based tool for real-time surveillance of disease outbreaks. Clin Infect Dis (2009) 3.90
Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum (2003) 3.05
A nuclear receptor-like pathway regulating multidrug resistance in fungi. Nature (2008) 3.00
Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis (2009) 2.72
Retracted Human immunodeficiency virus infection and the thyroid. Thyroid (2002) 2.68
Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci U S A (2009) 2.35
Medically important bacterial-fungal interactions. Nat Rev Microbiol (2010) 2.10
Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog (2007) 2.05
Virulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and mice. Infect Immun (2002) 1.96
Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence (2010) 1.88
Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother (2009) 1.86
Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med (2009) 1.84
Antibacterial bioagents based on principles of bacteriophage biology: an overview. Clin Infect Dis (2013) 1.70
The LRR and RING domain protein LRSAM1 is an E3 ligase crucial for ubiquitin-dependent autophagy of intracellular Salmonella Typhimurium. Cell Host Microbe (2012) 1.67
Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol (2010) 1.64
The prevalence and significance of methicillin-resistant Staphylococcus aureus colonization at admission in the general ICU Setting: a meta-analysis of published studies. Crit Care Med (2014) 1.61
Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog (2007) 1.55
Disruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence. Infect Immun (2004) 1.52
Using non-mammalian hosts to study fungal virulence and host defense. Curr Opin Microbiol (2006) 1.52
Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Proc Natl Acad Sci U S A (2008) 1.51
Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response. Eukaryot Cell (2004) 1.45
Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Lasers Surg Med (2010) 1.45
Dissection of the dislocation pathway for type I membrane proteins with a new small molecule inhibitor, eeyarestatin. Mol Biol Cell (2004) 1.44
Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain. Microbes Infect (2007) 1.44
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clin Infect Dis (2006) 1.42
Characterization and regulation of the trehalose synthesis pathway and its importance in the pathogenicity of Cryptococcus neoformans. Infect Immun (2006) 1.41
Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence. Mol Microbiol (2007) 1.38
Candida infection and colonization among trauma patients. Virulence (2010) 1.34
Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell (2009) 1.33
Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection. Infect Immun (2005) 1.33
Efflux in fungi: la pièce de résistance. PLoS Pathog (2009) 1.33
Our paths might cross: the role of the fungal cell wall integrity pathway in stress response and cross talk with other stress response pathways. Eukaryot Cell (2009) 1.28
Candida infection and colonization among non-trauma emergency surgery patients. Virulence (2010) 1.27
Candida albicans infection of Caenorhabditis elegans induces antifungal immune defenses. PLoS Pathog (2011) 1.24
Role of filamentation in Galleria mellonella killing by Candida albicans. Microbes Infect (2010) 1.23
Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS One (2009) 1.22
Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother (2008) 1.22
In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis. Infect Immun (2006) 1.21
The trehalose synthesis pathway is an integral part of the virulence composite for Cryptococcus gattii. Infect Immun (2009) 1.21
Contribution of gelatinase, serine protease, and fsr to the pathogenesis of Enterococcus faecalis endophthalmitis. Infect Immun (2004) 1.21
Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi. Cell Host Microbe (2011) 1.18
TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking. J Immunol (2010) 1.18
Eca1, a sarcoplasmic/endoplasmic reticulum Ca2+-ATPase, is involved in stress tolerance and virulence in Cryptococcus neoformans. Infect Immun (2007) 1.17
Natalizumab and HSV meningitis. J Neurovirol (2011) 1.16
Cryptococcus neoformans gene involved in mammalian pathogenesis identified by a Caenorhabditis elegans progeny-based approach. Infect Immun (2005) 1.13
Of model hosts and man: using Caenorhabditis elegans, Drosophila melanogaster and Galleria mellonella as model hosts for infectious disease research. Adv Exp Med Biol (2012) 1.12
Recruitment of CD63 to Cryptococcus neoformans phagosomes requires acidification. Proc Natl Acad Sci U S A (2006) 1.10
Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature. Medicine (Baltimore) (2012) 1.10
The challenge of managing fusariosis. Virulence (2011) 1.10
Models in the development of clinical practice guidelines. Ann Intern Med (2015) 1.08
Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages. J Immunol (2010) 1.08
Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol (2012) 1.07
Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity. Antimicrob Agents Chemother (2007) 1.05
Nocardiosis of the central nervous system: experience from a general hospital and review of 84 cases from the literature. Medicine (Baltimore) (2014) 1.05
T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med (2013) 1.05
4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity. Clin Infect Dis (2009) 1.05
Invertebrate models of fungal infection. Biochim Biophys Acta (2013) 1.03
Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies. PLoS One (2013) 1.00
Cytotoxicity of hydrogen peroxide produced by Enterococcus faecium. Infect Immun (2004) 1.00
Caenorhabditis elegans immune conditioning with the probiotic bacterium Lactobacillus acidophilus strain NCFM enhances gram-positive immune responses. Infect Immun (2012) 1.00
Selecting an invertebrate model host for the study of fungal pathogenesis. PLoS Pathog (2012) 0.99
Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem Biol (2010) 0.97
Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine (Baltimore) (2011) 0.97
Control and manipulation of pathogens with an optical trap for live cell imaging of intercellular interactions. PLoS One (2010) 0.96
Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance. Haematologica (2009) 0.96
Update on the epidemiology and management of cryptococcal meningitis. Expert Opin Pharmacother (2012) 0.96
A C. elegans-based, whole animal, in vivo screen for the identification of antifungal compounds. Nat Protoc (2008) 0.95
Antifungal activity of microbial secondary metabolites. PLoS One (2011) 0.94
Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates. BMC Microbiol (2011) 0.93
Fluconazole assists berberine to kill fluconazole-resistant Candida albicans. Antimicrob Agents Chemother (2013) 0.93
Immunoglobulin G signaling activates lysosome/phagosome docking. Proc Natl Acad Sci U S A (2006) 0.93
Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections. Clin Infect Dis (2012) 0.93
Monocyte- and macrophage-targeted NADPH oxidase mediates antifungal host defense and regulation of acute inflammation in mice. J Immunol (2013) 0.93
MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics (2014) 0.92
Interaction of Candida albicans with an intestinal pathogen, Salmonella enterica serovar Typhimurium. Eukaryot Cell (2009) 0.92
Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience. Biol Blood Marrow Transplant (2013) 0.91
Antifungal use in HIV infection. Expert Opin Pharmacother (2002) 0.91
Candida peritonitis: an update on the latest research and treatments. World J Surg (2011) 0.90
The pursuit of cryptococcal pathogenesis: heterologous hosts and the study of cryptococcal host-pathogen interactions. FEMS Yeast Res (2006) 0.90
Toll-like receptor 9 modulates macrophage antifungal effector function during innate recognition of Candida albicans and Saccharomyces cerevisiae. Infect Immun (2011) 0.90
Statin therapy and decreased incidence of positive Candida cultures among patients with type 2 diabetes mellitus undergoing gastrointestinal surgery. Mayo Clin Proc (2010) 0.89
Photodynamic and antibiotic therapy impair the pathogenesis of Enterococcus faecium in a whole animal insect model. PLoS One (2013) 0.89
In vitro and in vivo activities of pterostilbene against Candida albicans biofilms. Antimicrob Agents Chemother (2014) 0.88
Dectin-1 activation controls maturation of β-1,3-glucan-containing phagosomes. J Biol Chem (2013) 0.88
Correlation between Candida albicans biofilm formation and invasion of the invertebrate host Galleria mellonella. Future Microbiol (2014) 0.87
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations. Expert Opin Investig Drugs (2006) 0.87
The role of TLR4 896 A>G and 1196 C>T in susceptibility to infections: a review and meta-analysis of genetic association studies. PLoS One (2013) 0.87
Use of fungal derived polysaccharide-conjugated particles to probe Dectin-1 responses in innate immunity. Integr Biol (Camb) (2011) 0.87
Methicillin-resistant Staphylococcus aureus prevention strategies in the ICU: a clinical decision analysis*. Crit Care Med (2015) 0.86
Fusarium infection: report of 26 cases and review of 97 cases from the literature. Medicine (Baltimore) (2013) 0.86
Developments in the treatment of candidiasis: more choices and new challenges. Expert Opin Investig Drugs (2006) 0.86
Killing of Candida albicans filaments by Salmonella enterica serovar Typhimurium is mediated by sopB effectors, parts of a type III secretion system. Eukaryot Cell (2011) 0.85
From the outside in and the inside out: Antifungal immune responses in Caenorhabditis elegans. Virulence (2010) 0.85
The cell biology of the innate immune response to Aspergillus fumigatus. Ann N Y Acad Sci (2012) 0.84
The tetraspanin CD82 is specifically recruited to fungal and bacterial phagosomes prior to acidification. Infect Immun (2010) 0.83